Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

References for PMC Articles for PubMed (Select 7496932)

1.
2.

The IL-2/IL-2 receptor system: a current overview.

Taniguchi T, Minami Y.

Cell. 1993 Apr 9;73(1):5-8. Review. No abstract available.

PMID:
8462103
3.
4.

Natural killer cells and bone marrow transplantation.

Murphy WJ, Reynolds CW, Tiberghien P, Longo DL.

J Natl Cancer Inst. 1993 Sep 15;85(18):1475-82. Review.

PMID:
8360930
5.

Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.

Xun C, Brown SA, Jennings CD, Henslee-Downey PJ, Thompson JS.

Transplantation. 1993 Aug;56(2):409-17.

PMID:
8356598
6.

Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.

Vitolo D, Vujanovic NL, Rabinowich H, Schlesinger M, Herberman RB, Whiteside TL.

J Immunol. 1993 Aug 15;151(4):1926-37.

PMID:
8345189
8.

Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects.

Skoner DP, Whiteside TL, Wilson JW, Doyle WJ, Herberman RB, Fireman P.

J Allergy Clin Immunol. 1993 Nov;92(5):732-43.

PMID:
8227865
9.

The biology and pathology of Fc receptors.

Sandor M, Lynch RG.

J Clin Immunol. 1993 Jul;13(4):237-46. Review. No abstract available.

PMID:
8227284
10.
11.

Costimulatory signals are required for optimal proliferation of human natural killer cells.

Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.

J Immunol. 1993 Mar 1;150(5):1705-14.

PMID:
7679691
12.

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Caligiuri MA, Murray C, Robertson MJ, Wang E, Cochran K, Cameron C, Schow P, Ross ME, Klumpp TR, Soiffer RJ, et al.

J Clin Invest. 1993 Jan;91(1):123-32.

13.

Interferons in the treatment of human cancer.

Kirkwood JM, Ernstoff MS.

J Clin Oncol. 1984 Apr;2(4):336-52. Review.

PMID:
6323641
14.

Interleukin-2 augments natural killer cell activity.

Henney CS, Kuribayashi K, Kern DE, Gillis S.

Nature. 1981 May 28;291(5813):335-8. No abstract available.

PMID:
6164929
15.
16.

Generation of NK cell activity from human bone marrow.

Lotzová E, Savary CA.

J Immunol. 1987 Jul 1;139(1):279-84.

PMID:
3495600
17.

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, et al.

N Engl J Med. 1987 Apr 9;316(15):889-97.

PMID:
3493432
18.
19.

Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A.

Matera L, Muccioli G, Cesano A, Bellussi G, Genazzani E.

Brain Behav Immun. 1988 Mar;2(1):1-10.

PMID:
3179506
20.

Use of whole blood methods in assessment of immune parameters in immunodeficiency states.

Fletcher MA, Baron GC, Ashman MR, Fischl MA, Klimas NG.

Diagn Clin Immunol. 1987;5(2):69-81.

PMID:
3113759
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk